1yxv: Difference between revisions

New page: left|200px<br /> <applet load="1yxv" size="450" color="white" frame="true" align="right" spinBox="true" caption="1yxv, resolution 2.000Å" /> '''Crystal Structure ...
 
No edit summary
 
(14 intermediate revisions by the same user not shown)
Line 1: Line 1:
[[Image:1yxv.gif|left|200px]]<br />
<applet load="1yxv" size="450" color="white" frame="true" align="right" spinBox="true"
caption="1yxv, resolution 2.000&Aring;" />
'''Crystal Structure of Kinase Pim1 in complex with 3,4-Dihydroxy-1-methylquinolin-2(1H)-one'''<br />


==Overview==
==Crystal Structure of Kinase Pim1 in complex with 3,4-Dihydroxy-1-methylquinolin-2(1H)-one==
Pim1, a serine/threonine kinase, is involved in several biological, functions including cell survival, proliferation, and differentiation., While pim1 has been shown to be involved in several hematopoietic cancers, it was also recently identified as a target of aberrant somatic, hypermutation in diffuse large cell lymphoma (DLCL), the most common form, of non-Hodgkin's lymphoma. The crystal structures of Pim1 in apo form and, bound with AMPPNP have been solved and several unique features of Pim1, were identified, including the presence of an extra beta-hairpin in the, N-terminal lobe and an unusual conformation of the hinge connecting the, two lobes of the enzyme. While the apo Pim1 structure is nearly identical, with that reported recently, the structure of AMPPNP bound to Pim1 is, significantly different. Pim1 is unique among protein kinases due to the, presence of a proline residue at position 123 that precludes the formation, of the canonical second hydrogen bond between the hinge backbone and the, adenine moiety of ATP. One crystal structure reported here shows that, changing P123 to methionine, a common residue that offers the backbone, hydrogen bond to ATP, does not restore the ATP binding pocket of Pim1 to, that of a typical kinase. These unique structural features in Pim1 result, in novel binding modes of AMP and a known kinase inhibitor scaffold, as, shown by co-crystallography. In addition, the kinase activities of five, Pim1 mutants identified in DLCL patients have been determined. In each, case, the observed effects on kinase activity are consistent with the, predicted consequences of the mutation on the Pim1 structure. Finally, 70, co-crystal structures of low molecular mass, low-affinity compounds with, Pim1 have been solved in order to identify novel chemical classes as, potential Pim1 inhibitors. Based on the structural information, opportunities for optimization of one specific example are discussed.
<StructureSection load='1yxv' size='340' side='right'caption='[[1yxv]], [[Resolution|resolution]] 2.00&Aring;' scene=''>
== Structural highlights ==
<table><tr><td colspan='2'>[[1yxv]] is a 1 chain structure with sequence from [https://en.wikipedia.org/wiki/Homo_sapiens Homo sapiens]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=1YXV OCA]. For a <b>guided tour on the structure components</b> use [https://proteopedia.org/fgij/fg.htm?mol=1YXV FirstGlance]. <br>
</td></tr><tr id='method'><td class="sblockLbl"><b>[[Empirical_models|Method:]]</b></td><td class="sblockDat" id="methodDat">X-ray diffraction, [[Resolution|Resolution]] 2&#8491;</td></tr>
<tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat" id="ligandDat"><scene name='pdbligand=IMD:IMIDAZOLE'>IMD</scene>, <scene name='pdbligand=LI6:3,4-DIHYDROXY-1-METHYLQUINOLIN-2(1H)-ONE'>LI6</scene></td></tr>
<tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[https://proteopedia.org/fgij/fg.htm?mol=1yxv FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=1yxv OCA], [https://pdbe.org/1yxv PDBe], [https://www.rcsb.org/pdb/explore.do?structureId=1yxv RCSB], [https://www.ebi.ac.uk/pdbsum/1yxv PDBsum], [https://prosat.h-its.org/prosat/prosatexe?pdbcode=1yxv ProSAT]</span></td></tr>
</table>
== Function ==
[https://www.uniprot.org/uniprot/PIM1_HUMAN PIM1_HUMAN] Proto-oncogene with serine/threonine kinase activity involved in cell survival and cell proliferation and thus providing a selective advantage in tumorigenesis. Exerts its oncogenic activity through: the regulation of MYC transcriptional activity, the regulation of cell cycle progression and by phosphorylation and inhibition of proapoptotic proteins (BAD, MAP3K5, FOXO3). Phosphorylation of MYC leads to an increase of MYC protein stability and thereby an increase of transcriptional activity. The stabilization of MYC exerted by PIM1 might explain partly the strong synergism between these two oncogenes in tumorigenesis. Mediates survival signaling through phosphorylation of BAD, which induces release of the anti-apoptotic protein Bcl-X(L)/BCL2L1. Phosphorylation of MAP3K5, an other proapoptotic protein, by PIM1, significantly decreases MAP3K5 kinase activity and inhibits MAP3K5-mediated phosphorylation of JNK and JNK/p38MAPK subsequently reducing caspase-3 activation and cell apoptosis. Stimulates cell cycle progression at the G1-S and G2-M transitions by phosphorylation of CDC25A and CDC25C. Phosphorylation of CDKN1A, a regulator of cell cycle progression at G1, results in the relocation of CDKN1A to the cytoplasm and enhanced CDKN1A protein stability. Promote cell cycle progression and tumorigenesis by down-regulating expression of a regulator of cell cycle progression, CDKN1B, at both transcriptional and post-translational levels. Phosphorylation of CDKN1B,induces 14-3-3-proteins binding, nuclear export and proteasome-dependent degradation. May affect the structure or silencing of chromatin by phosphorylating HP1 gamma/CBX3. Acts also as a regulator of homing and migration of bone marrow cells involving functional interaction with the CXCL12-CXCR4 signaling axis.<ref>PMID:1825810</ref> <ref>PMID:10664448</ref> <ref>PMID:12431783</ref> <ref>PMID:15528381</ref> <ref>PMID:16356754</ref> <ref>PMID:18593906</ref> <ref>PMID:19749799</ref>
== Evolutionary Conservation ==
[[Image:Consurf_key_small.gif|200px|right]]
Check<jmol>
  <jmolCheckbox>
    <scriptWhenChecked>; select protein; define ~consurf_to_do selected; consurf_initial_scene = true; script "/wiki/ConSurf/yx/1yxv_consurf.spt"</scriptWhenChecked>
    <scriptWhenUnchecked>script /wiki/extensions/Proteopedia/spt/initialview01.spt</scriptWhenUnchecked>
    <text>to colour the structure by Evolutionary Conservation</text>
  </jmolCheckbox>
</jmol>, as determined by [http://consurfdb.tau.ac.il/ ConSurfDB]. You may read the [[Conservation%2C_Evolutionary|explanation]] of the method and the full data available from [http://bental.tau.ac.il/new_ConSurfDB/main_output.php?pdb_ID=1yxv ConSurf].
<div style="clear:both"></div>


==About this Structure==
==See Also==
1YXV is a [http://en.wikipedia.org/wiki/Single_protein Single protein] structure of sequence from [http://en.wikipedia.org/wiki/Homo_sapiens Homo sapiens] with IMD and LI6 as [http://en.wikipedia.org/wiki/ligands ligands]. Active as [http://en.wikipedia.org/wiki/Non-specific_serine/threonine_protein_kinase Non-specific serine/threonine protein kinase], with EC number [http://www.brenda-enzymes.info/php/result_flat.php4?ecno=2.7.11.1 2.7.11.1] Full crystallographic information is available from [http://ispc.weizmann.ac.il/oca-bin/ocashort?id=1YXV OCA].
*[[Serine/threonine protein kinase 3D structures|Serine/threonine protein kinase 3D structures]]
 
*[[3D structures of pim-1|3D structures of pim-1]]
==Reference==
== References ==
Crystal structures of proto-oncogene kinase Pim1: a target of aberrant somatic hypermutations in diffuse large cell lymphoma., Kumar A, Mandiyan V, Suzuki Y, Zhang C, Rice J, Tsai J, Artis DR, Ibrahim P, Bremer R, J Mol Biol. 2005 Apr 22;348(1):183-93. PMID:[http://ispc.weizmann.ac.il//pmbin/getpm?pmid=15808862 15808862]
<references/>
__TOC__
</StructureSection>
[[Category: Homo sapiens]]
[[Category: Homo sapiens]]
[[Category: Non-specific serine/threonine protein kinase]]
[[Category: Large Structures]]
[[Category: Single protein]]
[[Category: Artis DR]]
[[Category: Artis, D.R.]]
[[Category: Bremer R]]
[[Category: Bremer, R.]]
[[Category: Ibrahim P]]
[[Category: Ibrahim, P.]]
[[Category: Kumar A]]
[[Category: Kumar, A.]]
[[Category: Mandiyan V]]
[[Category: Mandiyan, V.]]
[[Category: Rice J]]
[[Category: Rice, J.]]
[[Category: Suzuki Y]]
[[Category: Suzuki, Y.]]
[[Category: Tsai J]]
[[Category: Tsai, J.]]
[[Category: Zhang C]]
[[Category: Zhang, C.]]
[[Category: IMD]]
[[Category: LI6]]
[[Category: ser/thr protein kinase]]
 
''Page seeded by [http://ispc.weizmann.ac.il/oca OCA ] on Mon Nov 12 20:26:34 2007''

Proteopedia Page Contributors and Editors (what is this?)Proteopedia Page Contributors and Editors (what is this?)

OCA